Mon-Fri: 10.00 AM - 6.00 PM
+1 (206) 906-9922
info@avmbiotech.com
View our Platforms

We Deliver Two Platform Technologies

Fully Human Biologics Manufacturing Cell Lines

Fully Human Biologics Manufacturing Cell Lines

Drug resistance develops in up to 60% of chronic biologic patients because non-human cell line manufacturing creates post-translational biologic...

Learn more
Control of Stem Cell Bio-Distribution

Control of Stem Cell Bio-Distribution

Rapid, high-affinity lymphatic sequestration of stem cells limits outcomes for Regenerative Medicine, CAR-T Immunotherapy & Cancer Treatment...

Learn more

Meet the Team

Theresa Deisher
Theresa Deisher
Founder & President
Email: tdeisher@avmbiotech.com Experience includes Amgen, Immunex & Genetech PhD, Stanford University, Molecular & Cellular...
Michael Kuran
EVP/Business Development
Take care of business development.
Peter Jarzyna
Peter Jarzyna
Lab Director
Lab Director
from the blog

Learn About Our Leading Technologies

Click Here

For Our Non-Confidential Slide Deck

Contact Us